IQVIA Holdings, Inc.
American multinational company serving the combined industries of health information technology and clinical research
IQV NYSE
ISIN US46266C1053 SEC CIK 1478242 LEI 549300W3R20NM4KQPH86
Follow Iqvia
Weekly email: filings, results
Revenue, last quarter
$4.4B
+8% vs same quarter last year
Net income
$350M
+5.7% vs same quarter last year
EPS, diluted
$2.10
+8.8% vs same quarter last year
Operating cash flow
$825M
−9.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $16.3B | $1.4B |
| FY24 | $15.4B | $1.4B |
| FY23 | $15B | $1.4B |
| FY22 | $14.4B | $1.1B |
| FY21 | $13.9B | $966M |
| FY20 | $11.4B | $279M |
| FY19 | $11.1B | $191M |
| FY18 | $10.4B | $259M |
| FY17 | $9.7B | $1.3B |
| FY16 | $6.8B | $72M |
| FY15 | $5.7B | $387M |
| FY14 | $5.5B | $357M |
| FY13 | $5.1B | $226.6M |
| FY12 | $4.9B | $177.5M |
| FY11 | $4.3B | $241.8M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | 13.4% | 8.3% |
| FY24 | - | 14.3% | 8.9% |
| FY23 | - | 13.2% | 9.1% |
| FY22 | - | 12.5% | 7.6% |
| FY21 | - | 10% | 7% |
| FY20 | - | 6.4% | 2.5% |
| FY19 | - | 7% | 1.7% |
| FY18 | - | 7.1% | 2.5% |
| FY17 | 52.4% | 6.9% | 13.2% |
| FY16 | 52.5% | 8.5% | 1.1% |
| FY15 | 52.8% | 11.3% | 6.7% |
| FY14 | 51.2% | 10.8% | 6.5% |
| FY13 | 51.5% | 9.1% | 4.4% |
| FY12 | 49.5% | 8.1% | 3.6% |
| FY11 | 50.3% | 8% | 5.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $2.1B |
| FY24 | $2.1B |
| FY23 | $1.5B |
| FY22 | $1.6B |
| FY21 | $2.3B |
| FY20 | $1.3B |
| FY19 | $835M |
| FY18 | $795M |
| FY17 | $601M |
| FY16 | $696M |
| FY15 | $398M |
| FY14 | $350M |
| FY13 | $305M |
| FY12 | $264.4M |
| FY11 | $85.3M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | - | $1.2B |
| FY24 | - | $1.4B |
| FY23 | - | $992M |
| FY22 | - | $1.2B |
| FY21 | - | $406M |
| FY20 | - | $447M |
| FY19 | - | $949M |
| FY18 | - | $1.4B |
| FY17 | - | $2.6B |
| FY16 | - | $1.1B |
| FY15 | - | $515M |
| FY14 | - | $415M |
| FY13 | - | $6.4M |
| FY12 | $567.9M | $13.4M |
| FY11 | $288.3M | $14.3M |
- Iqvia
- Healthcare median
Show the numbers
| Year | Iqvia | Healthcare median |
|---|---|---|
| FY25 | 8.3% | −30.6% |
| FY24 | 8.9% | −47% |
| FY23 | 9.1% | −58% |
| FY22 | 7.6% | −80.4% |
| FY21 | 7% | −71.9% |
| FY20 | 2.5% | −62.2% |
| FY19 | 1.7% | −46.3% |
| FY18 | 2.5% | −49.6% |
| FY17 | 13.2% | −45.9% |
| FY16 | 1.1% | −36% |
| FY15 | 6.7% | −38.4% |
| FY14 | 6.5% | −35.5% |
| FY13 | 4.4% | −37.1% |
| FY12 | 3.6% | −29.1% |
| FY11 | 5.6% | −27.9% |